Resultados de la búsqueda 621-630 of 4626 for Blood factor II
Blood-Brain Barrier Disruption (BBBD) for Liquid ... (2) early onset non-Alzheimer's Disease (EO-nonAD) ... To identify demographic, clinical and radiologic factors ...
This is a phase II multi-center study of nab-paclitaxel, gemcitabine and cisplatin (NGC triple regimen) as preoperative therapy in potentially resectable ...
A Study to Evaluate Immune-related Biomarkers for Pathological Response in Stage II-III HER2-positive Breast Cancer ... Human Blood and Tissues Repository for ...
We further examine whether blood biomarkers can replace or enhance the accuracy of advanced imaging in association with lesional bleeding. The project tests ...
The objective of this study is to collect tumor specimens (tumor tissues, matched normal tissue when possible, and 50 mL of blood) that may inform cancer ...
The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...
2. A second purpose of this study is to obtain blood and tissue samples from participants having or at risk for developing cancer of the liver or bile ducts or ...
... factors which influence survival ... Human Blood and Tissues Repository for Neuroscience Research ... Ir a página 22 · Ir a página 33 · Ir a página 44 · Ir a ...
... factors known to impact risk such as age, weight ... These include but are not limited to improvements in: (i) receiver coils; (ii) ... factors known to ...
... blood, and PET biomarkers. Numeración de páginas Estudios clínicos. AnteriorPágina anterior · Ir a página 11 · Ir a página 22 · Ir a página 33 · Ir a página 44 ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?